Cancer study a world first
Delcath Systems, Inc. has announced that the first fifty percent (46 of 92) of patients have been enrolled in the Phase III clinical trial treating metastatic cutaneous and ocular melanoma to the liver. The eleven participating cancer centers in this trial continue to evaluate and enroll patients and the Company looks forward to completing enrollment
Full Post: Delcath Systems enrols first fifty percent in trial treating metastatic cutaneous and ocular melanoma to the liver
A research study to recruit foreign language speaking cancer patients through Australian Cancer Registries will begin in New South Wales this month.
The study aims to assess anxiety, depression and quality of life in Greek, Chinese and Arabic speaking cancer patients in Australia. It will also document unmet needs and patterns of care throughout their cancer journey.
The University of Sydney will conduct the study in four Australian States and plan to survey 1,000 cancer patients.
Study participants will be adults aged 18-80, diagnosed with cancer between 2005 and 2006 and born in nations speaking Chinese (Mandarin or Cantonese), Arabic or Greek, and currently resident in Australia.
Cancer patients from culturally and linguistically diverse backgrounds have poorer quality of life following cancer treatment. They may experience difficulties within the Australian health system due to language barriers, poor knowledge of the healthcare system, differing beliefs and religion and social disadvantage.
The study’s Chief Investigator Professor Phyllis Butow said: “This will be the first study in the world to systematically explore outcomes in CALD (culturally and linguistically diverse) cancer patients using rigorous and culturally appropriate methodologies.
“Based on the information received from the survey, it will be possible to plan appropriate and targeted interventions, which we hope will lead to an increased quality of life following cancer treatment for these vulnerable populations.
“This information will be invaluable to all services wishing to provide culturally appropriate care for their cancer patients”, Professor Butow said.
Latina women who prefer speaking Spanish are more likely than other ethnic groups to express regret or dissatisfaction with their breast cancer treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center. Despite receiving similar treatment, Latina women were 5.6 times more likely than white women to report high
Full Post: Latina women more likely to regret breast cancer treatment decisions
Australian researchers say job stress is forcing many age care workers to leave and is jeopardising the industry. The researchers from the University of Melbourne warn that almost a third of registered aged care nurses are contemplating quitting their jobs because of job stress, created by excessive workloads, cost cutting, a hostile work environment and
Full Post: Age care in jeopardy as workers quit because of job stress
Smokers determined to quit the habit have been advised to wait until after the New Year before finally butting out. According to Quit, an organisation which offers help to smokers who want to stop, smokers intent on making a New Year’s resolution to knock the habit on the head should hold off for two
Full Post: Smokers advised to wait until after New Year to quit
According to the latest information cancer is on the increase in Australia. In a report by the Australian Institute of Health and Welfare on cancer statistics for 2008 new cancer cases are expected to increase by over 3,000 cases per year. The report shows that the number of new cancer cases diagnosed in Australia each
Full Post: Cancer is on the increase in Australia
Startling findings from a new CML (chronic myelogenous leukemia) patient survey were presented at a satellite meeting of the American Society of Hematology annual meeting, in San Francisco. The first-ever international CML patient web survey shows that the biggest challenge is coping with treatment side effects on a daily basis. An overwhelming 85% of respondents
Full Post: Chronic myelogenous leukemia patient survey shows that side effects are a serious issue